BRAIN-MAGNET: A novel functional genomics atlas coupled with convolutional neural networks facilitates clinical interpretation of disease relevant variants in non-coding regulatory elements
Ruizhi DengiD, Elena PerenthaleriD, Anita Nikoncuk, Soheil YousefiiD, Kristina LankoiD, Rachel SchotiD, Michela MarescaiD, Eva Medico SalsenchiD, Leslie E. SandersoniD, Michael James ParkeriD, Wilfred F. J. van IJckeniD, Joohyun ParkiD, Marc SturmiD, Tobias B. HaackiD, Gennady V. RoshchupkiniD, Eskeatnaf MulugetaiD, Tahsin Stefan BarakatiD
Abstract
Genome-wide assessment of genetic variation is becoming routine in human genetics, but functional interpretation of non-coding variants both in common and rare diseases remains extremely challenging. Here, we employed the massively parallel reporter assay ChIP- STARR-seq to functionally annotate the activity of >145 thousand non-coding regulatory elements (NCREs) in human neural stem cells, modelling early brain development. Highly active NCREs show increased sequence constraint and harbour de novo variants in individuals affected by neurodevelopmental disorders. They are enriched for transcription factor (TF) motifs including YY1 and p53 family members and for primate-specific transposable elements, providing insights on gene regulatory mechanisms in NSCs. Examining episomal NCRE activity of the same sequences in human embryonic stem cells identified cell type differential activity and primed NCREs, accompanied by a rewiring of the epigenome landscape. Leveraging the experimentally measured NCRE activity and nucleotide composition of the assessed sequences, we built BRAIN-MAGNET, a functionally validated convolutional neural network that predicts NCRE activity based on DNA sequence composition and identifies functionally relevant nucleotides required for NCRE function. The application of BRAIN-MAGNET allows fine-mapping of GWAS loci identified for common neurological traits and prioritizing of possible disease-causing rare non-coding variants in currently genetically unexplained individuals with neurogenetic disorders, including those from the Genomics England 100,000 Genomes project, identifying novel enhanceropathies. We foresee that this NCRE atlas and BRAIN-MAGNET will help reduce missing heritability in human genetics by limiting the search space for functionally relevant non-coding genetic variation. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/24305761v2_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@eace29org.highwire.dtl.DTLVardef@184f59aorg.highwire.dtl.DTLVardef@18772borg.highwire.dtl.DTLVardef@37c4d2_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Massively parallel characterization and predictive modelling of neuronal regulatory variation
Kilian Salomon, Chengyu Deng, … Martin Kircher·bioRxiv·Jul 17, 2026
- Mapping the regulatory effects of common and rare non-coding variants across cellular and developmental contexts in the brain and heart
Andrew R. Marderstein, Soumya Kundu, … Stephen B. Montgomery·bioRxiv·Feb 18, 2025
- Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort
Olga M. Sigalova, Alexandra Pančíková, … Stein Aerts·bioRxiv·Apr 16, 2026
- Comprehensive multi-omics integration identifies differentially active enhancers during human brain development with clinical relevance
Soheil Yousefi, Ruizhi Deng, … Tahsin Stefan Barakat·Genome MedicinePeer-reviewed·Oct 18, 2021
- Evidence for enhancer noncoding RNAs (enhancer-ncRNAs) with gene regulatory functions relevant to neurodevelopmental disorders
Yazdan Asgari, Julian Ik‐Tsen Heng, … Hamid Alinejad‐Rokny·bioRxiv·May 16, 2020
- Individuals with intellectual disability have an increased burden of de novo variants in cis-regulatory elements of glutamatergic neurons.
Eric Sosa, Dónal O’Shea, … John M. Greally·medRxiv·Sep 23, 2025